Consumer Health

Sleep aids is projected to post fast retail volume growth over 2023. The category saw spikes in demand in 2020 and 2021 as the stress and anxiety of the Coronavirus (COVID-19) pandemic increased the incidence of sleep disorders or complaints. While…

Sales of sleep aids are seeing more stable growth in 2023 after the peaks achieved in 2020-2021 when the pandemic created widespread anxiety and insomnia. Many people had to work from home and home-school their children during times of lockdown and…

During 2023, sleep aids continued to benefit from the post- pandemic landscape of ongoing global economic instability, compounded by rampant inflation, which placed pressure on both middle- and low-income groups. As a result, consumers were forced to…

Demand for paediatric consumer health remains strong and rising in 2023, driven by increasing attention to children’s overall health and wellbeing, and consistent consumer education in Vietnam. An increasing mindset of prevention is prompting some…

It is evident that the average consumer has become more health-conscious since COVID-19, as seen through transformations in ingredient-focused product development in dermatologicals, alongside the rise of natural remedies and botanical compositions…

In the United Arab Emirates, there is wide knowledge of consumer health, due to the diverse make-up of the population. However, there are a significant number of parents who continue to be hesitant to give children over-the-counter medications due to…

Over 2023, paediatric consumer health retail current value sales are expected to continue to grow healthily. On the other hand, retail volume development is projected to be marginal-to-moderate, with declines anticipated for paediatric acetaminophen…

The sales performances recorded in each of the categories that comprise paediatric consumer health during 2023 were determined to some extent by the performances recorded in each of these categories in 2020, during the early stages of the COVID-19…

Growth in paediatric consumer health current value sales in 2023 is expected to surpass that recorded in 2022, as are volume growth rates for all product categories. This improvement is partly attributable to relatively high birth rates in Morocco,…

Paediatric consumer health is expected to see strong growth in current value terms in 2023, with most categories projected to post a positive performance in value and volume terms. Volume sales are benefiting from the increase in unit prices…

In 2023, paediatric consumer health continues to witness a strong performance, with current value sales predicted to be higher than in the previous year. In the years following the pandemic, the increase spread of common viruses and lower levels of…

Paediatric consumer health is performing well in 2023 for the second consecutive year, albeit at a much lower pace of current value growth than in 2022. Ireland witnessed a more intense season of common colds and viruses among children in 2022 as the…

The re-opening of schools and the lifting of COVID-19 restrictions, such as compulsory use of face masks in schools, is leading to strong growth for multiple categories within paediatric consumer health. For example, sales of lice/anti-parasitic…

The pandemic led to a higher containment of flu and bronchiolitis in France due to prolonged home seclusion, which negatively impacted children’s immunity. The impact of this is becoming increasingly evident as young consumers now interact with one…

Paediatric consumer health is expected to register a slight increase in current value sales, but a fall in volume sales. The performance of vitamins in particular is expected to drag down the overall segment. Vitamins are the largest product in…

Despite challenging macroeconomic conditions in the country and higher prices for just about everything, paediatric consumer health managed to record positive growth over the review period and in 2023, reflecting the importance families place on the…

Paediatric analgesics saw only modest volume growth in 2023 as a result of a return to pre-pandemic consumption habits. More robust current value growth was partly the result of inflationary pressures due to the ongoing conflict in Ukraine, which has…

The preference for herbal/traditional products has grown in recent years, driven by the rising demand for natural and clean ingredients. This trend is evident across the whole of consumer healthcare, but is particularly prominent in paediatric…

Paediatric analgesics faced supply issues during 2022 and part of 2023, particularly with a scarcity of Dolex 7+ (a suspension that can be used for children aged 7 and above that has a different concentration from baby drops and adult acetaminophen).…

Notwithstanding the decline in the birth rate and the contraction in the infant population, which has had a direct negative impact on categories such as milk formula, it has not depressed demand for upgraded consumption in paediatric consumer health.…